ACADIA Pharmaceuticals Inc
ACAD27.550USD
-0.320-1.15%
Market hours （ET）Quotes delayed by 15 min
4.66BMarket Cap
17.59P/E TTM
ACADIA Pharmaceuticals Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
957.80M
31.85%
EPS(YoY)
1.37
465.26%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of ACADIA Pharmaceuticals Inc?
According to ACADIA Pharmaceuticals Inc's FY2024 earnings report, its total revenue reached 957.80M, with a year-on-year change of 31.85%.
What is the Earnings Per Share (EPS) of ACADIA Pharmaceuticals Inc?
According to ACADIA Pharmaceuticals Inc's FY2024 earnings report, its Earnings Per Share (EPS) was 1.366, with a year-on-year change of 465.26%.
What is the net income of ACADIA Pharmaceuticals Inc?
According to ACADIA Pharmaceuticals Inc's FY2024 earnings report, its net income was 226.45M, with a year-on-year change of 469.50%.
What is the net margin of ACADIA Pharmaceuticals Inc?
According to ACADIA Pharmaceuticals Inc's FY2024 earnings report, its net profit margin was 23.64%, with a year-on-year change of 380.24%.
What is the gross margin of ACADIA Pharmaceuticals Inc?
According to ACADIA Pharmaceuticals Inc's FY2024 earnings report, its gross margin was 91.46%, with a year-on-year change of -2.98%.
What is the debt-to-asset ratio of ACADIA Pharmaceuticals Inc?
According to ACADIA Pharmaceuticals Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of ACADIA Pharmaceuticals Inc?
According to ACADIA Pharmaceuticals Inc's FY2024 earnings report, its Return on Equity (ROE) was 38.89%, with a year-on-year change of 364.04%.
What is the Return on Assets (ROA) of ACADIA Pharmaceuticals Inc?
According to ACADIA Pharmaceuticals Inc's FY2024 earnings report, its Return on Assets (ROA) was 23.39%, with a year-on-year change of 355.04%.
What is the operating profit of ACADIA Pharmaceuticals Inc?
According to ACADIA Pharmaceuticals Inc's FY2024 earnings report, its operating profit was 84.28M, with a year-on-year change of 214.85%.
What are the current assets of ACADIA Pharmaceuticals Inc?
According to ACADIA Pharmaceuticals Inc's FY2024 earnings report, its current assets were 938.32M, with a year-on-year change of 52.29%.
What are the total assets of ACADIA Pharmaceuticals Inc?
According to ACADIA Pharmaceuticals Inc's FY2024 earnings report, its total assets of ACADIA Pharmaceuticals Inc were 1.19B, with a year-on-year change of 58.59%.
What are the total liabilities of ACADIA Pharmaceuticals Inc?
According to ACADIA Pharmaceuticals Inc's FY2024 earnings report, its total liabilities of ACADIA Pharmaceuticals Inc were 454.96M, with a year-on-year change of 43.43%.
What is the total equity of ACADIA Pharmaceuticals Inc?
According to ACADIA Pharmaceuticals Inc's FY2024 earnings report, its total equity of ACADIA Pharmaceuticals Inc was 732.79M, with a year-on-year change of 69.72%.
What is the net operating income of ACADIA Pharmaceuticals Inc?
According to ACADIA Pharmaceuticals Inc's FY2024 earnings report, its net operating income of ACADIA Pharmaceuticals Inc was 226.45M, with a year-on-year change of 469.50%.
What is the net investment of ACADIA Pharmaceuticals Inc?
According to ACADIA Pharmaceuticals Inc's FY2024 earnings report, its net investment of ACADIA Pharmaceuticals Inc was -30.54M, with a year-on-year change of -195.44%.
What is the net financing of ACADIA Pharmaceuticals Inc?
According to ACADIA Pharmaceuticals Inc's FY2024 earnings report, its net financing of ACADIA Pharmaceuticals Inc was 6.84M, with a year-on-year change of -72.76%.
